Scipher Medicine’s PrismRA Validated for Hispanic RA Patients
Scipher Medicine announces the successful validation of its PrismRA trial, which shows improved outcomes for Hispanic patients suffering from rheumatoid arthritis (RA). This study addresses significant healthcare disparities and aims to enhance treatment efficacy in this demographic population.
BURLINGTON, MA, UNITED STATES, April 28, 2026 /EINPresswire.com/ — Scipher Medicine, a leader in precision medicine for autoimmune diseases, today highlighted a publication of peer-reviewed, real-world evidence showing that its molecular treatment …